{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:41:23Z","timestamp":1793104883171,"version":"4.5.0"},"reference-count":47,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Pain"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>The consumption of opioids has increased globally since the 1990s. Previous studies of global opioid consumption have concentrated on morphine alone or a subset of opioids, with a focus on cancer pain and palliative care. In this study, we have determined the global, regional, and national consumption of all controlled opioids, including anaesthetics, analgesics, antidiarrheals, opioid substitution therapies, and cough suppressants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a cross-sectional study using data from the International Narcotics Control Board (INCB). We calculated mean opioid consumption (mg\/person) globally, regionally, and nationally for 2015\u20132017, where consumption refers to the total amount of controlled opioids distributed for medical purposes and excludes recreational use. We ranked countries by total consumption and quantified the types of opioids consumed globally.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Between 2015 and 2017, 90% of the world\u2019s population consumed only 11% of controlled opioids. An average of 32 mg\/person was consumed annually, but this was not equally distributed across the world. Consumption was the highest in Germany (480 mg\/person), followed by Iceland (428 mg\/person), the United States (398 mg\/person) and Canada (333 mg\/person). Oxycodone (35%) was the most heavily consumed controlled opioid globally, followed by morphine (15.9%), methadone (15.8%) and tilidine (14%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Large disparities persist in most of the world in accessing essential opioid medicines. Consumption patterns should continue to be monitored, and collaborative strategies should be developed to promote access and the appropriate prescribing of opioids in all countries and non-metropolitan territories.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20494637211013052","type":"journal-article","created":{"date-parts":[[2021,5,9]],"date-time":"2021-05-09T02:31:13Z","timestamp":1620527473000},"page":"34-40","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":53,"title":["Global, regional, and national consumption of controlled opioids: a cross-sectional study of 214 countries and non-metropolitan territories"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0244-5620","authenticated-orcid":false,"given":"Georgia C","family":"Richards","sequence":"first","affiliation":[{"name":"Global Centre on Healthcare and Urbanisation, Kellogg College, University of Oxford, Oxford, UK"},{"name":"Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey K","family":"Aronson","sequence":"additional","affiliation":[{"name":"Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal R","family":"Mahtani","sequence":"additional","affiliation":[{"name":"Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Heneghan","sequence":"additional","affiliation":[{"name":"Global Centre on Healthcare and Urbanisation, Kellogg College, University of Oxford, Oxford, UK"},{"name":"Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,5,4]]},"reference":[{"key":"bibr1-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-8"},{"key":"bibr2-20494637211013052","unstructured":"WHO. World Health Organization model list of essential medicines, 21st list. Geneva: World Health Organization, 2019, https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/igo\/ (accessed 25 October 2020)."},{"key":"bibr3-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-003563"},{"key":"bibr4-20494637211013052","unstructured":"Ventafridda V, Saita L, Ripamonti C, et al. WHO guidelines for the use of analgesics in cancer pain. Int J Tissue React 1985; 7(1): 93\u201396, https:\/\/pubmed.ncbi.nlm.nih.gov\/2409039\/ (accessed 2 March 2021)."},{"key":"bibr5-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i20"},{"key":"bibr6-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2017.11.098"},{"key":"bibr7-20494637211013052","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2018.304753"},{"key":"bibr8-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00161-6"},{"key":"bibr9-20494637211013052","doi-asserted-by":"publisher","DOI":"10.3109\/15360288.2014.941132"},{"key":"bibr10-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2012.03.011"},{"key":"bibr11-20494637211013052","unstructured":"United Nations Single Convention on Narcotic Drugs, 1961, https:\/\/www.emcdda.europa.eu\/drugs-library\/single-convention-narcotic-drugs-1961_en (1961, accessed 6 August 2020)."},{"key":"bibr12-20494637211013052","unstructured":"INCB. Mandate-functions. Vienna: International Narcotic Control Board, 2019, https:\/\/www.incb.org\/incb\/en\/about\/mandate-functions.html (accessed 29 April 2020)."},{"key":"bibr13-20494637211013052","unstructured":"INCB. Narcotic drugs \u2013 estimated world requirements for 2020 \u2013 statistics for 2019. Vienna: International Narcotic Control Board, 2019, https:\/\/www.incb.org\/documents\/Narcotic-Drugs\/Technical-Publications\/2020\/Narcotic_Drugs_Technical_publication_2020.pdf (accessed 25 October 2020)."},{"key":"bibr14-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(18)30471-1"},{"key":"bibr15-20494637211013052","doi-asserted-by":"publisher","DOI":"10.3399\/bjgpopen20X101122"},{"key":"bibr16-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(19)30128-8"},{"key":"bibr17-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1291"},{"key":"bibr18-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k3207"},{"key":"bibr19-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01528-7"},{"key":"bibr20-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4369"},{"key":"bibr21-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2013.03.015"},{"key":"bibr22-20494637211013052","doi-asserted-by":"publisher","DOI":"10.3109\/15360288.2010.536307"},{"key":"bibr23-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1337"},{"key":"bibr24-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2017.0595"},{"key":"bibr25-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00365-4"},{"key":"bibr26-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2015.08.012"},{"key":"bibr27-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2015.0051"},{"key":"bibr28-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp581"},{"key":"bibr29-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt498"},{"key":"bibr30-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32229-9"},{"key":"bibr31-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32513-8"},{"key":"bibr32-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1177\/0269216312461973"},{"key":"bibr33-20494637211013052","unstructured":"Thomas J. Availability of narcotic drugs for medical use. Vienna: International Narcotic Control Board, 2019, https:\/\/www.incb.org\/incb\/en\/narcotic-drugs\/Availability\/availability.html (accessed 19 November 2019)."},{"key":"bibr34-20494637211013052","unstructured":"StataCorp. Create variable containing percentiles. Stata documentation, https:\/\/www.stata.com\/manuals\/dpctile.pdf (2020, accessed 16 March 2021)."},{"key":"bibr35-20494637211013052","unstructured":"StataCorp. Stata Statistical Software, Release 16. College Station, TX: StataCorp, 2019."},{"key":"bibr36-20494637211013052","unstructured":"Richards GC, Aronson JK, Heneghan C, et al. Global, regional & national consumption of controlled opioids. OSF, https:\/\/osf.io\/6nzds\/ (2020, accessed 8 February 2021)."},{"key":"bibr37-20494637211013052","unstructured":"Richards G. opioid_emls_maps\/Opioid consumption maps.ipynb. Github. p.georgiarichards\/opioid_emls_maps, https:\/\/github.com\/georgiarichards\/opioid_emls_maps\/blob\/master\/Opioidconsumptionmaps.ipynb (2020, accessed 8 February 2021)."},{"key":"bibr38-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.0665"},{"key":"bibr39-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.3931"},{"key":"bibr40-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001078"},{"key":"bibr41-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.06.010"},{"key":"bibr42-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4374"},{"key":"bibr43-20494637211013052","unstructured":"NICE. Project information| Chronic pain: assessment and management, https:\/\/www.nice.org.uk\/guidance\/indevelopment\/gid-ng10069 (2021, accessed 5 March 2021)."},{"key":"bibr44-20494637211013052","unstructured":"Kinetz E. Fake doctors, pilfered medical records drive Oxy China sales. Associated Press, 20 November, https:\/\/apnews.com\/4122af46fdba42119ae3db30aa13537c (2019, accessed 14 May 2020)."},{"key":"bibr45-20494637211013052","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2018.304833"},{"key":"bibr46-20494637211013052","unstructured":"WHO. Defined daily dose (DDD), https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/about-ddd (2021, accessed 5 March 2021)."},{"key":"bibr47-20494637211013052","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4168"}],"container-title":["British Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20494637211013052","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20494637211013052","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20494637211013052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:21:29Z","timestamp":1777382489000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20494637211013052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1177\/20494637211013052"],"URL":"https:\/\/doi.org\/10.1177\/20494637211013052","relation":{},"ISSN":["2049-4637","2049-4645"],"issn-type":[{"value":"2049-4637","type":"print"},{"value":"2049-4645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,4]]}}}